Clinical Pharmacokinetics of Metoprolol: A Systematic Review

Metoprolol. [cited; Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Metoprolol. Accessed 10 Oct 2021.

Brogden RN, Heel RC, Speight TM, Avery GS. Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. Drugs. 1977;14(5):321–48.

Morris J, Dunham A. Metoprolol. Treasure Island: StatPearls Publishing; 2018.

Google Scholar 

Jorge R, Chaves L, da Silva CA, et al. Alternative management of circumscribed choroidal hemangioma using intravitreal metoprolol. Retinal Cases Brief Reports. 2022;16(1):106–10.

PubMed  Article  Google Scholar 

Tubic-Grozdanis M, Bolger MB, Langguth P, et al. Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds. AAPS J. 2008;10(1):213–26.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Regårdh C-G, Johnsson G. Clinical pharmacokinetics of metoprolol. Clin Pharmacokinet. 1980;5(6):557–69.

PubMed  Article  Google Scholar 

Berger B, Bachmann F, Duthaler U, et al. Cytochrome P450 enzymes involved in metoprolol metabolism and use of metoprolol as a CYP2D6 phenotyping probe drug. Front Pharmacol. 2018;9:774.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Lukacova V, Woltosz WS, Bolger MB. Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data. AAPS J. 2009;11(2):323–34.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Brocker CN, Velenosi T, Flaten HK, et al. Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. Hum Genom. 2020;14(1):1–9.

Article  CAS  Google Scholar 

Regårdh CG, Borg KO, Johansson R, et al. Pharmacokinetic studies on the selectiveβ 1-receptor antagonist metoprolol in man. J Pharmacokinet Biopharm. 1974;2(4):347–64.

PubMed  Article  Google Scholar 

Mateus A, Matsson PR, Artursson P. A high-throughput cell-based method to predict the unbound drug fraction in the brain. J Med Chem. 2014;57(7):3005–10.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Benfield P, Clissold SP, Brogden RN. Metoprolol. Drugs. 1986;31(5):376–429.

CAS  PubMed  Article  Google Scholar 

Neil-Dwyer G, Bartlett J, McAinsh J, et al. Beta-adrenoceptor blockers and the blood-brian barrier. Br J Clin Pharmacol. 1981;11(6):549–53.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Younis W, Asif H, Sharif A, et al. Traditional medicinal plants used for respiratory disorders in Pakistan: a review of the ethno-medicinal and pharmacological evidence. Chin Med. 2018;13(1):1–29.

Article  CAS  Google Scholar 

Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA. 2002;287(17):2215–20.

PubMed  Article  Google Scholar 

Regårdh C-G, Jordö L, Ervik M, et al. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis. Clin Pharmacokinet. 1981;6(5):375–88.

PubMed  Article  Google Scholar 

Jordö L, Attman P, Aurell M, et al. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function. Clin Pharmacokinet. 1980;5(2):169–80.

PubMed  Article  Google Scholar 

Meloche M, Khazaka M, Kassem I, et al. CYP2D6 polymorphism and its impact on the clinical response to metoprolol: a systematic review and meta-analysis. Br J Clin Pharmacol. 2020;86(6):1015–33.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Higgins J. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration. www cochrane-handbook org. 2011.

Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41.

PubMed  Article  Google Scholar 

Clark HD, Wells GA, Huët C, et al. Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials. 1999;20(5):448–52.

CAS  PubMed  Article  Google Scholar 

Al-Dirini RMA, Thewlis D, Paul G. A comprehensive literature review of the pelvis and the lower extremity FE human models under quasi-static conditions. Work. 2012;41(Supplement 1):4218–29.

PubMed  Article  Google Scholar 

Regårdh C-G, Johnsson G, Jordö L, et al. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol. J Cardiovasc Pharmacol. 1980;2(6):715–23.

PubMed  Article  Google Scholar 

Godbillon J, Evard D, Vidon N, et al. Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol. 1985;19(S2):113S-S118.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Richard J, Cardot J, Godbillon J. Inter-and intra-subject variability of metoprolol kinetics after intravenous administration. Eur J Drug Metab Pharmacokinet. 1994;19(2):157–62.

CAS  PubMed  Article  Google Scholar 

Larsson M, Landahl S, Lundborg P, et al. Pharmacokinetics of metoprolol in healthy, elderly, non-smoking individuals after a single dose and two weeks of treatment. Eur J Clin Pharmacol. 1984;27(2):217–22.

CAS  PubMed  Article  Google Scholar 

Kendall M, John V, Quarterman C, et al. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metoprolol. Eur J Clin Pharmacol. 1980;17(2):87–92.

CAS  PubMed  Article  Google Scholar 

Sandberg A, Blomqvist I, Jonsson U, et al. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets. Eur J Clin Pharmacol. 1988;33(1):S9–14.

CAS  PubMed  Article  Google Scholar 

Oosterhuis B, Jonkman J, Kerkhof F. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation. Eur J Clin Pharmacol. 1988;33(1):S15–8.

CAS  PubMed  Article  Google Scholar 

Oosterhuis B, Jonkman J, Zuiderwijk P, et al. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation. J Clin Pharmacol. 1990;30(S2):S33–8.

CAS  PubMed  Article  Google Scholar 

Wieselgren I, Lundborg P, Sandberg A, et al. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled release (CR/ZOK) 50 mg in young subjects. J Clin Pharmacol. 1990;30(S2):S28–32.

CAS  PubMed  Article  Google Scholar 

Lücker P, Moore G, Wieselgren I, et al. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses. J Clin Pharmacol. 1990;30(S2):S17–27.

PubMed  Article  Google Scholar 

Darmansjah I, Wong E, Setiawati A, et al. Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenolol. J Clin Pharmacol. 1990;30(S2):S39–45.

CAS  PubMed  Article  Google Scholar 

Dimenäs E, Dahlöf C, Heibel B, et al. Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects—a comparison with atenolol. Eur J Clin Pharmacol. 1990;38(6):571–8.

PubMed  Article  Google Scholar 

Lundborg P, Abrahamsson B, Wieselgren I, et al. The pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers. Eur J Clin Pharmacol. 1993;45(2):161–3.

CAS  PubMed  Article  Google Scholar 

Jin S, Chung H, Chung M, et al. Influence of CYP2D6* 10 on the pharmacokinetics of metoprolol in healthy Korean volunteers. J Clin Pharm Ther. 2008;33(5):567–73.

CAS  PubMed  Article  Google Scholar 

Luzier AB, Killian A, Wilton JH, et al. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther. 1999;66(6):594–601.

CAS  PubMed  Article  Google Scholar 

Cerqueira PM, Cesarino EJ, Mateus FH, et al. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients. Chirality. 1999;11(7):591–7.

CAS  PubMed  Article  Google Scholar 

Held P, Regårdh C-G. Metoprolol in acute myocardial infarction. A pharmacokinetic and pharmacodynamic study. Eur J Clin Pharmacol. 1986;31(3):261–5.

CAS  PubMed  Article  Google Scholar 

Everts B, Karlson B, Herlitz J, et al. Effects and pharmacokinetics of high dose metoprolol on chest pain in patients with suspected or definite acute myocardial infarction. Eur J Clin Pharmacol. 1997;53(1):23–31.

CAS  PubMed  Article  Google Scholar 

Kendall M, Quarterman C, Jack D, et al. Metoprolol pharmacokinetics and the oral contraceptive pill. Br J Clin Pharmacol. 1982;14(1):120.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jack DB, Kendall MJ, Dean S, et al. The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutolol. Biopharm Drug Dispos. 1982;3(1):47–54.

CAS  PubMed  Article 

留言 (0)

沒有登入
gif